Publications by authors named "Donald Chun"

Claim this Profile
P
Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection.
Donna M Konicek, Adam J Plaunt, Sachin Gharse, Sasha J Rose, Arielle Dorfman, Donald Chun

Pharmaceutics· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Brensocatib, an oral, reversible inhibitor of dipeptidyl peptidase 1, mitigates interferon-α-accelerated lupus nephritis in mice.
Kuan-Ju Chen, Jimin Zhang, Daniel LaSala, Jessica Basso, Donald Chun

Front Immunol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pharmacokinetic profile of brensocatib and its effect on pharmacodynamic biomarkers including NE, PR3, and CatG in various rodent species.
Jessica Basso, Kuan-Ju Chen, Yuchen Zhou, Lilly Mark, Daniel LaSala, Donald Chun

Front Pharmacol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction for Plaunt et al., "Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections".
Adam J Plaunt, Sasha J Rose, Jeong Yeon Kang, Kuan-Ju Chen, Daniel LaSala, Donald Chun

Antimicrob Agents Chemother· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Inhaled Treprostinil Palmitil, Inhaled and Intravenous Treprostinil, and Oral Selexipag in a Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.
Michel R Corboz, Adam J Plaunt, Vladimir S Malinin, Zhili Li, Helena Gauani, Donald Chun

J Pharmacol Exp Ther· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treprostinil palmitil inhibits the hemodynamic and histopathological changes in the pulmonary vasculature and heart in an animal model of pulmonary arterial hypertension.
Michel R Corboz, Adam J Plaunt, Vladimir Malinin, Zhili Li, Helena Gauani, Donald Chun

Eur J Pharmacol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Preclinical Evaluation of New Inhaled Lipoglycopeptides for the Treatment of Persistent Pulmonary Methicillin-Resistant Staphylococcus aureus Infections.
Adam J Plaunt, Sasha J Rose, Jeong Yeon Kang, Kuan-Ju Chen, Daniel LaSala, Donald Chun

Antimicrob Agents Chemother· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treprostinil palmitil, an inhaled long-acting pulmonary vasodilator, does not show tachyphylaxis with daily dosing in rats.
Richard W Chapman, Zhili Li, Donald Chun, Helena Gauani, Vladimir Malinin

Pulm Pharmacol Ther· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension.
Adam J Plaunt, Sadikul Islam, Tony Macaluso, Helena Gauani, Thomas Baker, Donald Chun

Int J Mol Sci· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cell-based assay for screening the uridine 5(')-diphosphate-glucuronosyltransferase 1A inhibitory potential of new chemical entities.
Jaime Padrós, Donald Chun, Liangfu Chen, Pierre Rigolli, Themis Flarakos

Anal Biochem· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis